FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1967477040> ?p ?o ?g. }

• W1967477040 endingPage "88" @default.
• W1967477040 startingPage "81" @default.
• W1967477040 abstract "Dipeptidyl peptidase 4 (DPP-4) inhibitors are proposed to lower blood glucose in type 2 diabetes mellitus (T2DM) by prolonging the activity of the circulating incretins, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1). Consistent with this mechanism of action, DPP-4 inhibitors improve glucose tolerance after meals by increasing insulin and reducing glucagon levels in the plasma. However, DPP-4 inhibitors also reduce fasting blood glucose, an unexpected effect because circulating levels of active GIP and GLP-1 are low in the postabsorptive state.The objective of the study was to examine the effects of DPP-4 inhibition on fasting islet function.We conducted a randomized, double-blind, placebo-controlled trial.The study was performed in General Clinical Research Centers at two University Hospitals.Forty-one subjects with T2DM were treated with metformin or diet, having good glycemic control with glycosylated hemoglobin values of 6.2-7.5%.Subjects were treated with vildagliptin (50 mg twice daily) or placebo for 3 months, followed by a 2-wk washout. Major Outcome Measure: We measured insulin secretion in response to iv glucose and arginine before and after treatment and after drug washout.There were small and comparable reductions in glycosylated hemoglobin in both groups over 3 months. Vildagliptin increased fasting GLP-1 levels in subjects taking metformin, but not those managed with diet, and raised active GIP levels slightly. DPP-4 inhibitor treatment improved the acute insulin and C-peptide responses to glucose (50 and 100% respectively; P < 0.05) and increased the slope of the C-peptide response to glucose (33%; P = 0.023).Vildagliptin improves islet function in T2DM under fasting conditions. This suggests that DPP-4 inhibition has metabolic benefits in addition to enhancing meal-induced GLP-1 and GIP activity." @default.
• W1967477040 created "2016-06-24" @default.
• W1967477040 creator A5011056162 @default.
• W1967477040 creator A5016030681 @default.
• W1967477040 creator A5018229325 @default.
• W1967477040 creator A5024842101 @default.
• W1967477040 creator A5030538841 @default.
• W1967477040 creator A5043199807 @default.
• W1967477040 creator A5058011326 @default.
• W1967477040 creator A5059098934 @default.
• W1967477040 creator A5066047147 @default.
• W1967477040 creator A5071074041 @default.
• W1967477040 creator A5085000723 @default.
• W1967477040 date "2009-01-01" @default.
• W1967477040 modified "2023-09-26" @default.
• W1967477040 title "Treatment with the Dipeptidyl Peptidase-4 Inhibitor Vildagliptin Improves Fasting Islet-Cell Function in Subjects with Type 2 Diabetes" @default.
• W1967477040 cites W1969480413 @default.
• W1967477040 cites W1969628999 @default.
• W1967477040 cites W1970498822 @default.
• W1967477040 cites W1971244959 @default.
• W1967477040 cites W1978953702 @default.
• W1967477040 cites W1989976483 @default.
• W1967477040 cites W1991565451 @default.
• W1967477040 cites W1997008557 @default.
• W1967477040 cites W2000083483 @default.
• W1967477040 cites W2031468509 @default.
• W1967477040 cites W2032322539 @default.
• W1967477040 cites W2036167841 @default.
• W1967477040 cites W2043121816 @default.
• W1967477040 cites W2043869817 @default.
• W1967477040 cites W2047353065 @default.
• W1967477040 cites W2063976195 @default.
• W1967477040 cites W2077149049 @default.
• W1967477040 cites W2081392051 @default.
• W1967477040 cites W2084948079 @default.
• W1967477040 cites W2085862152 @default.
• W1967477040 cites W2086547011 @default.
• W1967477040 cites W2089095955 @default.
• W1967477040 cites W2101293928 @default.
• W1967477040 cites W2106833597 @default.
• W1967477040 cites W2109432892 @default.
• W1967477040 cites W2120467396 @default.
• W1967477040 cites W2121497054 @default.
• W1967477040 cites W2124020657 @default.
• W1967477040 cites W2125624587 @default.
• W1967477040 cites W2129546109 @default.
• W1967477040 cites W2140369318 @default.
• W1967477040 cites W2147883561 @default.
• W1967477040 cites W2156150085 @default.
• W1967477040 cites W2157841460 @default.
• W1967477040 cites W2164961795 @default.
• W1967477040 cites W2167621077 @default.
• W1967477040 cites W2283519284 @default.
• W1967477040 cites W2487142160 @default.
• W1967477040 doi "https://doi.org/10.1210/jc.2008-1135" @default.
• W1967477040 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2630874" @default.
• W1967477040 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18957505" @default.
• W1967477040 hasPublicationYear "2009" @default.
• W1967477040 type Work @default.
• W1967477040 sameAs 1967477040 @default.
• W1967477040 citedByCount "85" @default.
• W1967477040 countsByYear W19674770402012 @default.
• W1967477040 countsByYear W19674770402013 @default.
• W1967477040 countsByYear W19674770402014 @default.
• W1967477040 countsByYear W19674770402015 @default.
• W1967477040 countsByYear W19674770402016 @default.
• W1967477040 countsByYear W19674770402017 @default.
• W1967477040 countsByYear W19674770402018 @default.
• W1967477040 countsByYear W19674770402019 @default.
• W1967477040 countsByYear W19674770402020 @default.
• W1967477040 countsByYear W19674770402021 @default.
• W1967477040 countsByYear W19674770402022 @default.
• W1967477040 countsByYear W19674770402023 @default.
• W1967477040 crossrefType "journal-article" @default.
• W1967477040 hasAuthorship W1967477040A5011056162 @default.
• W1967477040 hasAuthorship W1967477040A5016030681 @default.
• W1967477040 hasAuthorship W1967477040A5018229325 @default.
• W1967477040 hasAuthorship W1967477040A5024842101 @default.
• W1967477040 hasAuthorship W1967477040A5030538841 @default.
• W1967477040 hasAuthorship W1967477040A5043199807 @default.
• W1967477040 hasAuthorship W1967477040A5058011326 @default.
• W1967477040 hasAuthorship W1967477040A5059098934 @default.
• W1967477040 hasAuthorship W1967477040A5066047147 @default.
• W1967477040 hasAuthorship W1967477040A5071074041 @default.
• W1967477040 hasAuthorship W1967477040A5085000723 @default.
• W1967477040 hasBestOaLocation W19674770402 @default.
• W1967477040 hasConcept C126322002 @default.
• W1967477040 hasConcept C134018914 @default.
• W1967477040 hasConcept C142724271 @default.
• W1967477040 hasConcept C156490143 @default.
• W1967477040 hasConcept C165220095 @default.
• W1967477040 hasConcept C181199279 @default.
• W1967477040 hasConcept C185592680 @default.
• W1967477040 hasConcept C204787440 @default.
• W1967477040 hasConcept C27081682 @default.
• W1967477040 hasConcept C2776398474 @default.
• W1967477040 hasConcept C2776453732 @default.
• W1967477040 hasConcept C2777180221 @default.

• next